SAN FRANCISCO, Sept. 18, 2017 -- Zephyr Health, the leading Insights-as-a-Service solution provider for Life Sciences companies, today announced the launch of Relationship Analytics, the latest addition to its award-winning enterprise solution, Zephyr IlluminateTM. These new analytic capabilities are designed to meet the needs of Life Sciences professionals looking to understand and capitalize on healthcare provider (HCP) and organization’s (HCO) relationships and networks for more effective stakeholder engagement and decision-making.
Today, Life Sciences teams rely primarily upon personal industry knowledge or field input in customer relationship marketing (CRM) systems to identify relationships or network insights on HCPs and HCOs, according to a recently published survey report of over 110 Life Sciences professionals. Over 71% of respondents agreed that understanding these complex relationships is increasingly important for their strategic brand initiatives. Surprisingly, however, the survey revealed that only 6% of respondents are using digital insights regularly to map or uncover customer relationships and networks.
“Despite the availability of data on HCP and HCO relationships and networks, many Life Sciences professionals are still unable to leverage this information to support their customer outreach efforts,” said Lance Scott, president and CEO of Zephyr Health. “Relationship Analytics bridges the gap between disparate data and actionable next steps by unlocking valuable new insights on timely and relevant factors influencing HCP and HCO behaviors, and ultimately decision-making.”
Relationship Analytics puts an HCP or HCO’s relative network into medical and market context based on type, importance and strength of relevant connections. With these new insights, Life Sciences companies can quickly measure and compare relationships such as: physician and account referral potential, co-authorship and co-investigator potential, speaker bureau attendee’s potential, and more. Here are just a few examples of how Relationship Analytics can be deployed:
- Account Referral Potential - measure and compare account referral potential by treatment experience, geographic proximity and volume of historical referrals from the physician
- Peer Referral Potential - easily identify top referring providers based upon shared patient data, therapy-specific relationships and historical referrals
- Co-authorship Potential - understand a provider’s publication network and identify shared interests and common research with co-authors or co-investigators
- Speaker Program Potential - identify high potential attendees or speakers based upon shared interests, shared patients, similar event attendance patterns, and common research or publication relationships
About Zephyr Health
Zephyr Health helps Life Sciences companies – pharmaceutical, biotech, medical device and diagnostics – engage the right physicians, accounts and institutions using insights from global health data. Zephyr Illuminate™ is a leading Insights-as-a-Service solution that integrates thousands of data sources to create precise and predictive insights. From pre-launch to product maturity, Life Sciences companies can make confident decisions faster with data-driven targeting and deep customer profiles.
Zephyr Health is a privately held company headquartered in San Francisco with offices in London, UK, and Pune, India. Zephyr Health is venture backed by Google Ventures, Kleiner Perkins Caufield & Byers and Icon Ventures. For more information, please visit: www.zephyrhealth.com.
Media Contact:


Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Washington Post Publisher Will Lewis Steps Down After Layoffs
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 



